Senate Defeats Amendment to Enforce Hemp Ban, Extends Legal Window to December
The US Senate rejected an amendment by Sen. Ted Budd (R-NC) that would have enforced the scheduled federal recriminalization of hemp-derived THC products on November 12. Instead, the chamber passed a continuing resolution that delays the ban until December 11, allowing more time for regulatory frameworks. The vote was 90-6 for the underlying bill, with a 61-32 vote to table Budd’s amendment. This move aligns with White House pressure to replace prohibition with regulations for low-dose hemp products, though it excludes synthetic cannabinoids, which remain banned. Industry groups and some lawmakers argue the delay provides a chance to establish safety standards, while opponents warn of public health risks.
Key points
- Senate voted 61-32 to table an amendment by Sen. Ted Budd that would have removed provisions delaying the hemp ban.
- The Senate passed the continuing resolution by 90-6, extending the legal status of most hemp THC products until December 11.
- The delay excludes synthetic cannabinoids, which will still be recriminalized on November 12.
- White House officials, including CMS Director Mehmet Oz, supported the delay to protect Medicare coverage initiatives for hemp-derived CBD.
- Industry groups like BAMCO and WSWA backed the delay to push for a regulatory framework for hemp beverages within the alcohol system.
Background
In early August, the Senate Appropriations Committee had already proposed delaying the hemp ban to December 11 as part of a funding bill, a move supported by the White House and industry advocates. Prior to this, states like Texas had enacted stricter bans on hemp-derived THC, and the North Carolina legislature was debating similar measures. The federal delay follows a series of executive actions and legislative pushes by President Trump to redefine hemp regulations to protect full-spectrum CBD products, which he cited as beneficial for veterans and chronic pain sufferers. The current delay is part of a broader effort to replace prohibition with a regulatory framework, though no comprehensive federal law has yet been passed.
Why it matters
The delay prevents the immediate federal recriminalization of hemp-derived THC products, which could have removed a significant portion of the market, including popular CBD and low-dose THC beverages. It provides a window for Congress to develop regulations that balance consumer safety with industry interests, potentially integrating hemp products into existing alcohol frameworks. However, the exclusion of synthetic cannabinoids and the lack of a final regulatory framework leave uncertainty for businesses and consumers, while opponents argue the delay prolongs public health risks associated with unregulated intoxicating hemp products.
What to watch
Congress is expected to continue debating regulatory bills, including proposals from Rep. Andy Barr and potential Senate companions from Sens. Tim Sheehy and Amy Klobuchar. The White House has committed to no further extensions of the ban’s effective date if the current resolution is enacted, meaning December 11 remains the deadline for a regulatory framework. Industry groups will likely push for integration into the three-tier alcohol system, while law enforcement and public health advocates may continue to urge stricter controls or immediate enforcement of the ban.
- Senate Votes To Delay Hemp Ban, Giving Lawmakers More Time To Craft Regulations To Keep THC Products Legal Marijuana Moment
- Senate tables hemp amendment at center of funding fight, allowing one-month delay of ban The Hill
- ‘Reefer Madness’: White House’s hemp reversal divides GOP — and sparks conflict of interest concerns MS NOW
- Trump Seeks a Boost for Hemp That Would Benefit a Top Aide’s Family The New York Times
- The White House's Push To Pause the Hemp Ban Smells Like Cronyism Reason Magazine
Want the full story? Read the original reporting
Read on Marijuana Moment